Eulav Asset Management Becton Dickinson & CO Transaction History

Eulav Asset Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$236.45 - $266.82 $7.27 Million - $8.2 Million	-30,730 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$230.58 - $256.08 $2.77 Million - $3.07 Million	-12,000 Reduced 28.08%	30,730 $7.77 Million
Q2 2019 Aug 05, 2019	SELL	$217.4 - $246.08 $3.47 Million - $3.93 Million	-15,974 Reduced 27.21%	42,730 $10.8 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $6.94 Million - $8.17 Million	36,704 Added 166.84%	58,704 $12.6 Million
Q3 2017 Nov 14, 2017	SELL	$186.89 - $198.9 $53,263 - $56,686	-285 Reduced 1.28%	22,000 $4.31 Million
Q2 2017 Aug 14, 2017	BUY	N/A	22,285	22,285 $4.35 Million

1,739

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $66.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.